Home> Products> conclusion gliclaglaze

{ "products": [ { "_id": "6662b5442bed1f08484d6a79", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "METROTREX 2.5 ", "description": "METROTREX 2.5 \nMethotrexate (2.5mg)\nMETROTREX 2.5 is a medication containing Methotrexate in a 2.5mg dosage. Methotrexate is a versatile drug used to treat a variety of conditions, including certain types of cancer, and autoimmune diseases like rheumatoid arthritis, psoriasis, and inflammatory bowel disease.\n\nKey Features of METROTREX 2.5 (Methotrexate 2.5mg):\n\nTreatment of Cancer: Methotrexate is commonly used in the treatment of various types of cancer, including leukemia, lymphoma, and certain types of solid tumors. It works by interfering with the growth and spread of cancer cells in the body.\n\nAutoimmune Diseases: METROTREX 2.5 is also effective in managing autoimmune diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. It helps to reduce inflammation and relieve symptoms associated with these conditions.\n\nDosage and Administration: The typical dosage of METROTREX 2.5 (Methotrexate 2.5mg) varies depending on the condition being treated and the patient's response to the medication. It is usually taken once a week, and the dosage may be adjusted by a healthcare provider based on individual needs.\n\nSide Effects: Like all medications, METROTREX 2.5 can cause side effects. Common side effects may include nausea, vomiting, loss of appetite, dizziness, and hair loss. It is important to report any severe or persistent side effects to a healthcare professional.\n\nPrecautions: Patients taking METROTREX 2.5 should follow their healthcare provider's instructions carefully. It is important to avoid alcohol while taking this medication, as it can increase the risk of liver damage. Pregnant women should not take Methotrexate due to the risk of harm to the fetus.\n\nMonitoring: Regular monitoring of blood counts and liver function may be necessary while taking METROTREX 2.5 to ensure safe and effective treatment.\n\nIn conclusion, METROTREX 2.5 (Methotrexate 2.5mg) is a valuable medication used in the treatment of cancer and autoimmune diseases. It is essential to use this medication under the guidance of a healthcare professional and to be aware of potential side effects and precautions.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\nhttps://www.sterisonline.com/product/metrotrex-2-5-133666\n\n\n\n\n\n\n", "price": 86.0, "discountamount": 26.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "body", "risk", "Call", "harm", "safe", "fetus", "Email", "Order", "spread", "growth", "severe", "nausea", "variety", "alcohol", "patient", "lymphoma", "symptoms", "response", "appetite", "vomiting", "guidance", "WhatsApp", "leukemia", "dizziness", "METROTREX", "psoriasis", "hair loss", "conclusion", "conditions", "medications", "Precautions", "information", "instructions", "inflammation", "sterisonline", "cancer cells", "Key Features", "solid tumors", "liver damage", "blood counts", "2.5mg dosage", "various types", "versatile drug", "Pregnant women", "typical dosage", "Administration", "liver function", "individual needs", "Regular monitoring", "Methotrexate 2.5mg", "valuable medication", "healthcare provider", "effective treatment", "autoimmune diseases", "Common side effects", "rheumatoid arthritis", "potential side effects", "healthcare professional", "persistent side effects", "inflammatory bowel disease" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1503, "imageuri": "https://productimages.withfloats.com/actual/667d4597cd6f42ac0460a63a.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d4597cd6f42ac0460a63a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T07:22:44.849Z", "updatedon": "2024-06-27T10:57:26.774Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/metrotrex-2-5-/1503", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METROTREX 2.5 ", "category": "NEPHROLOGYRANGE", "tags": [ "methotrexate 2.5 mg tablet dose", "methotrexate dose", "methotrexate 2.5 mg tablet price", "methotrexate 2.5 mg for rheumatoid arthritis" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662aa04db100e1fdc2dcb68", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE 100 ", "description": "VILDIABATE 100 \nVildagliptin (100mg)\nVILDIABATE 100 is a medication designed to manage type 2 diabetes mellitus by targeting specific aspects of glucose regulation. It contains Vildagliptin, an oral antidiabetic agent that belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. Vildagliptin works by inhibiting the enzyme DPP-4, which is responsible for degrading incretin hormones like GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide).\n\nHere are key points about VILDIABATE 100:\n\nMechanism of Action: Vildagliptin acts by inhibiting DPP-4, thereby increasing the levels of GLP-1 and GIP. These hormones play crucial roles in glucose metabolism:\n\nGLP-1 stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner. It also inhibits glucagon secretion, reduces appetite, and slows gastric emptying.\nGIP enhances insulin release in response to meals, contributing to postprandial glucose control.\nBlood Sugar Control: By enhancing insulin secretion and reducing glucagon levels, VILDIABATE 100 helps lower blood sugar levels, especially after meals. This mechanism targets both fasting and postprandial hyperglycemia, contributing to overall glycemic control.\n\nDosage and Administration: VILDIABATE 100 is typically taken orally once daily, preferably with a meal to maximize its effects on postprandial glucose levels. The dosage may vary depending on individual needs and response to treatment. It's essential to follow your healthcare provider's instructions regarding dosage and timing.\n\nEfficacy and Safety: Clinical studies have demonstrated the efficacy of Vildagliptin in lowering HbA1c levels (a marker of long-term glucose control) and improving glycemic parameters. It is generally well-tolerated, with common side effects including headache, nasopharyngitis (inflammation of the nose and throat), and upper respiratory tract infections. Serious side effects are rare but may include pancreatitis or hypersensitivity reactions.\n\nCombination Therapy: VILDIABATE 100 may be prescribed as monotherapy or in combination with other antidiabetic medications such as metformin or sulfonylureas. Combining medications with different mechanisms of action can provide synergistic benefits in managing diabetes.\n\nMonitoring and Follow-Up: Regular monitoring of blood sugar levels, kidney function, and other relevant parameters is important during treatment with VILDIABATE 100. Your healthcare provider may adjust the dosage or add/modify other medications based on your response and individual needs.\n\nLifestyle Modifications: In addition to medication, lifestyle modifications such as a healthy diet, regular exercise, weight management, and avoiding tobacco and excessive alcohol intake are essential components of diabetes management.\n\nIn conclusion, VILDIABATE 100 containing Vildagliptin is an effective oral antidiabetic medication that helps regulate blood sugar levels in patients with type 2 diabetes. It acts by enhancing insulin secretion and reducing postprandial glucose levels, contributing to improved glycemic control. However, it should be used under medical supervision, and adherence to prescribed dosage and lifestyle recommendations is crucial for optimal diabetes management.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-100-133452\n\n\n\n\n\n", "price": 275.0, "discountamount": 82.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "nose", "GLP-1", "EMAIL", "class", "meals", "Order", "timing", "throat", "enzyme", "Safety", "Dosage", "marker", "tobacco", "fasting", "response", "addition", "appetite", "headache", "patients", "Efficacy", "metformin", "Follow-Up", "adherence", "treatment", "VILDIABATE", "conclusion", "key points", "information", "monotherapy", "healthy diet", "instructions", "sterisonline", "pancreatitis", "inflammation", "sterispharma", "HbA1c levels", "CALL/WHATSAPP", "sulfonylureas", "crucial roles", "Administration", "insulin release", "nasopharyngitis", "kidney function", "glucagon levels", "gastric emptying", "specific aspects", "Clinical studies", "individual needs", "regular exercise", "other medications", "Vildagliptin acts", "incretin hormones", "DPP-4) inhibitors", "weight management", "insulin secretion", "glucose metabolism", "glucose regulation", "glucagon secretion", "blood sugar levels", "Regular monitoring", "Combination Therapy", "glycemic parameters", "common side effects", "Blood Sugar Control", "medical supervision", "healthcare provider", "essential components", "synergistic benefits", "different mechanisms", "Serious side effects", "pancreatic beta cells", "dipeptidyl peptidase-4", "oral antidiabetic agent", "Lifestyle Modifications", "glucose-dependent manner", "excessive alcohol intake", "overall glycemic control", "type 2 diabetes mellitus", "lifestyle recommendations", "other relevant parameters", "long-term glucose control", "hypersensitivity reactions", "postprandial hyperglycemia", "optimal diabetes management", "postprandial glucose levels", "postprandial glucose control", "other antidiabetic medications", "upper respiratory tract infections", "effective oral antidiabetic medication", "glucose-dependent insulinotropic peptide" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1491, "imageuri": "https://productimages.withfloats.com/actual/6662aa0b364f23242470b3ca.png", "tileimageuri": "https://productimages.withfloats.com/tile/6662aa0b364f23242470b3ca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T06:34:44.056Z", "updatedon": "2024-06-28T11:58:50.164Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-100-/1491", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VILDIABATE 100 ", "category": "DIABETIC RANGE", "tags": [ "VILDIABATE 100", "Vildagliptin (100mg)", "Vildagliptin 100 mg uses", "Vildagliptin 100 mg price", "Vildagliptin 100 mg SR brand Name", "Vildagliptin 100 mg brands in India", "", "Vildagliptin 100 mg generic medicine", "Vildagliptin 100 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661afd366170d1ff8cb4626", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIGLICLAGLAZE 60 ", "description": "TRIGLICLAGLAZE 60 \nGliclazide 60mg (SR) Pioglitazone 15mg and Metformin HCL 500mg(SR)\nTRIGLICLAGLAZE 60 is a combination medication designed to effectively manage type 2 diabetes mellitus by addressing multiple aspects of glucose regulation. It combines three key components: Gliclazide 60mg (SR), Pioglitazone 15mg, and Metformin HCI 500mg (SR), each contributing to improved blood sugar control through distinct mechanisms of action.\n\nGliclazide 60mg (SR): Gliclazide is a sulfonylurea medication that stimulates the pancreas to release insulin. This insulin release helps lower blood sugar levels, especially after meals, by facilitating glucose uptake into cells.\n\nPioglitazone 15mg: Pioglitazone belongs to the thiazolidinedione class and works by improving insulin sensitivity in peripheral tissues such as muscle and fat cells. Enhanced insulin sensitivity allows for better utilization of glucose, reducing insulin resistance and promoting more efficient blood sugar management.\n\nMetformin HCI 500mg (SR): Metformin is a biguanide medication that primarily works by reducing glucose production in the liver and increasing insulin sensitivity in muscle cells. It also improves glucose uptake by cells and reduces the absorption of glucose from the digestive tract.\n\nKey Benefits of TRIGLICLAGLAZE 60:\nComprehensive Glucose Control: By combining Gliclazide (SR), Pioglitazone, and Metformin HCI (SR), TRIGLICLAGLAZE 60 offers comprehensive control over blood sugar levels throughout the day.\n\nStimulates Insulin Release: Gliclazide's action in stimulating insulin release from the pancreas helps manage postprandial (after-meal) glucose spikes, contributing to overall glucose control.\n\nImproves Insulin Sensitivity: Pioglitazone enhances insulin sensitivity in tissues, leading to better glucose uptake and utilization by cells. This helps reduce insulin resistance, a common feature of type 2 diabetes.\n\nReduces Glucose Production: Metformin HCI lowers glucose production in the liver and improves insulin action in muscle cells, leading to lower fasting blood sugar levels and enhanced glucose utilization.\n\nExtended Release Formulation: The sustained-release formulations of Gliclazide and Metformin ensure a gradual and prolonged release of the medications, providing consistent blood sugar control and minimizing the risk of hypoglycemia or hyperglycemia.\n\nDosage and Administration:\nTRIGLICLAGLAZE 60 is typically taken orally once or twice daily, with meals to reduce gastrointestinal side effects.\nDosage adjustments may be required based on blood sugar levels and individual response to treatment. Follow your healthcare provider's instructions.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/trigliclaglaze-60-134279", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "SR", "day", "risk", "meals", "Order", "liver", "EMAIL", "gradual", "fasting", "pancreas", "Enhanced", "treatment", "fat cells", "absorption", "information", "medications", "muscle cells", "Pioglitazone", "sterisonline", "Key Benefits", "hypoglycemia", "instructions", "sterispharma", "postprandial", "hyperglycemia", "CALL/WHATSAPP", "Metformin HCL", "Metformin HCI", "Administration", "glucose uptake", "TRIGLICLAGLAZE", "common feature", "glucose spikes", "insulin action", "insulin release", "Gliclazide 60mg", "digestive tract", "multiple aspects", "prolonged release", "Dosage adjustments", "peripheral tissues", "blood sugar levels", "glucose production", "insulin resistance", "glucose regulation", "distinct mechanisms", "healthcare provider", "individual response", "glucose utilization", "insulin sensitivity", "three key components", "biguanide medication", "comprehensive control", "combination medication", "sulfonylurea medication", "thiazolidinedione class", "overall glucose control", "type 2 diabetes mellitus", "Extended Release Formulation", "Comprehensive Glucose Control", "gastrointestinal side effects", "sustained-release formulations", "consistent blood sugar control", "efficient blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1485, "imageuri": "https://productimages.withfloats.com/actual/6661afd7f21358d53af3cd71.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661afd7f21358d53af3cd71.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:47:15.16Z", "updatedon": "2024-06-28T12:12:27Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trigliclaglaze-60-/1485", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIGLICLAGLAZE 60 ", "category": "DIABETIC RANGE", "tags": [ "TRIGLICLAGLAZE 60", "Gliclazide 60mg (SR)", "Pioglitazone 15mg", "Metformin HCL 500mg(SR)", "Metformin SR 500mg uses", "Metformin SR 500 price", "Metformin SR 500 side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661af452bed1f08484d625b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIGLICLAGLAZE 30 ", "description": "TRIGLICLAGLAZE 30 \nGliclazide (SR) Pioglitazone and Metformin HCL (SR)\nTRIGLICLAGLAZE 30 is a combination medication formulated to manage type 2 diabetes mellitus effectively. It combines three key components: Gliclazide (SR), Pioglitazone, and Metformin HCI (SR), each targeting different aspects of glucose regulation to achieve optimal blood sugar control.\n\nGliclazide (SR): Gliclazide is a sulfonylurea medication that works by stimulating the pancreas to release insulin, which helps lower blood sugar levels. The sustained-release (SR) formulation ensures a gradual and prolonged release of the medication, providing consistent glucose-lowering effects throughout the day.\n\nPioglitazone: Pioglitazone belongs to the thiazolidinedione class of drugs and enhances insulin sensitivity in muscle and fat tissues. By improving the body's response to insulin, Pioglitazone helps reduce insulin resistance and promotes better glucose utilization by cells.\n\nMetformin HCI (SR): Metformin is a biguanide medication that works primarily by reducing glucose production in the liver and increasing insulin sensitivity in peripheral tissues. The sustained-release formulation ensures a gradual release of Metformin, minimizing gastrointestinal side effects and providing extended blood sugar control.\n\nKey Benefits of TRIGLICLAGLAZE 30:\nComprehensive Glucose Control: The combination of Gliclazide (SR), Pioglitazone, and Metformin HCI (SR) targets multiple pathways involved in glucose metabolism. This comprehensive approach helps achieve better overall blood sugar control throughout the day.\n\nStimulates Insulin Release: Gliclazide stimulates insulin secretion from the pancreas, especially after meals, which is crucial for managing postprandial (after-meal) glucose spikes.\n\nImproves Insulin Sensitivity: Pioglitazone enhances insulin sensitivity in muscle and fat tissues, allowing for better glucose uptake and utilization by cells. This action helps reduce insulin resistance, a hallmark of type 2 diabetes.\n\nReduces Hepatic Glucose Production: Metformin HCI (SR) reduces the production of glucose in the liver, helping to lower fasting blood sugar levels and prevent excessive glucose release into the bloodstream.\n\nExtended Blood Sugar Control: The sustained-release formulations of Gliclazide and Metformin ensure a gradual and prolonged release of the medications, leading to consistent blood sugar control and minimizing the risk of hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar) fluctuations.\n\nDosage and Administration:\nTRIGLICLAGLAZE 30 is typically taken orally once or twice daily, as prescribed by a healthcare provider.\nThe medication is often taken with meals to reduce the risk of gastrointestinal side effects.\nDosage adjustments may be necessary based on blood sugar levels and individual response to treatment. Follow your doctor's instructions carefully.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/trigliclaglaze-30-134278", "price": 125.0, "discountamount": 37.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "risk", "drugs", "meals", "Order", "liver", "cells", "EMAIL", "doctor", "muscle", "action", "pancreas", "hallmark", "treatment", "Gliclazide", "fat tissues", "information", "medications", "bloodstream", "Pioglitazone", "sterisonline", "postprandial", "hypoglycemia", "fluctuations", "instructions", "sterispharma", "Key Benefits", "hyperglycemia", "CALL/WHATSAPP", "Metformin HCL", "Metformin HCI", "glucose uptake", "Administration", "TRIGLICLAGLAZE", "low blood sugar", "gradual release", "Insulin Release", "high blood sugar", "prolonged release", "insulin secretion", "different aspects", "multiple pathways", "peripheral tissues", "insulin resistance", "Dosage adjustments", "blood sugar levels", "glucose metabolism", "glucose regulation", "glucose utilization", "individual response", "insulin sensitivity", "healthcare provider", "meal) glucose spikes", "three key components", "biguanide medication", "combination medication", "comprehensive approach", "thiazolidinedione class", "sulfonylurea medication", "type 2 diabetes mellitus", "excessive glucose release", "Hepatic Glucose Production", "overall blood sugar control", "optimal blood sugar control", "extended blood sugar control", "gastrointestinal side effects", "sustained-release formulation", "Comprehensive Glucose Control", "consistent blood sugar control", "sustained-release (SR) formulation", "consistent glucose-lowering effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1484, "imageuri": "https://productimages.withfloats.com/actual/6661af49f21358d53af3ccec.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661af49f21358d53af3ccec.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:44:53.071Z", "updatedon": "2024-06-28T12:15:14.626Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trigliclaglaze-30-/1484", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIGLICLAGLAZE 30 ", "category": "DIABETIC RANGE", "tags": [ "TRIGLICLAGLAZE 30", "Gliclazide (SR)", "Pioglitazone", "Metformin HCL (SR)", "Metformin SR 500mg uses", "Metformin hydrochloride 500 mg", "Metformin SR 500 side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661a33aa743fd235822160e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "KETONALOG ALFA ", "description": "KETONALOG ALFA \nAlpha Keto analogue\nKetonalog Alfa is a pharmaceutical product that contains Alpha Keto analogue as its active ingredient. Alpha Keto analogue is a synthetic compound designed to mimic the metabolic effects of ketones in the body. It is commonly used in the treatment of metabolic disorders and conditions where ketone supplementation is beneficial.\n\nKetonalog Alfa works by providing a source of energy that can be utilized by cells when glucose availability is limited, such as during fasting or low-carbohydrate diets. This can help improve energy levels and metabolic function in individuals with certain metabolic conditions.\n\nThe recommended dosage of Ketonalog Alfa may vary depending on the specific condition being treated and the patient's individual needs. It is important to follow the dosage instructions provided by your healthcare provider.\n\nPossible side effects of Ketonalog Alfa may include gastrointestinal discomfort, headache, and dizziness. It is important to consult with a healthcare professional before starting any new medication, especially if you have any underlying health conditions or are taking other medications.\n\nIn conclusion, Ketonalog Alfa with Alpha Keto analogue offers a potential therapeutic option for managing metabolic disorders and supporting metabolic function. However, it is essential to use this medication under medical supervision and follow the recommended dosage guidelines.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/ketonalog-alfa-133661\n\n\n\n\n\n\n", "price": 371.0, "discountamount": 112.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "body", "Email", "cells", "source", "fasting", "ketones", "patient", "WhatsApp", "headache", "dizziness", "treatment", "conclusion", "individuals", "information", "sterispharma", "sterisonline", "energy levels", "new medication", "KETONALOG ALFA", "individual needs", "dosage guidelines", "other medications", "metabolic effects", "active ingredient", "specific condition", "recommended dosage", "metabolic function", "synthetic compound", "Alpha Keto analogue", "healthcare provider", "dosage instructions", "medical supervision", "metabolic disorders", "metabolic conditions", "glucose availability", "Possible side effects", "ketone supplementation", "low-carbohydrate diets", "pharmaceutical product", "healthcare professional", "gastrointestinal discomfort", "underlying health conditions", "potential therapeutic option" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1469, "imageuri": "https://productimages.withfloats.com/actual/6661a33b4328177af1d12fde.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661a33b4328177af1d12fde.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T11:53:30.26Z", "updatedon": "2024-06-29T05:33:29.109Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ketonalog-alfa-/1469", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "KETONALOG ALFA ", "category": "NEPHROLOGYRANGE", "tags": [ "KETONALOG ALFA", "Alpha Keto analogue", "Alpha Ketoanalogue tablets uses", "Alpha Ketoanalogue Tablet Price", "Alpha Ketoanalogue Tablet dosage", "Alpha Ketoanalogue mechanism of action", "Alpha Ketoanalogue side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66618961ea22b014e8af2676", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MYCOAZITHER 250", "description": "MYCOAZITHER 250\nAzithromycin (250mg)\nMYCOAZITHER 250 is a medication containing Azithromycin 250mg. Azithromycin is an antibiotic used to treat a wide range of bacterial infections. It works by stopping the growth of bacteria, helping your body to fight off the infection.\n\nThis medicine is commonly prescribed for respiratory tract infections, such as pneumonia, bronchitis, and sinusitis. It is also effective against skin infections, ear infections, and certain sexually transmitted diseases like chlamydia.\n\nThe recommended dosage of MYCOAZITHER 250 varies depending on the type and severity of the infection. It is usually taken once daily, with or without food. It's important to complete the full course of treatment as prescribed by your doctor, even if you start feeling better before finishing the medication.\n\nSide effects of MYCOAZITHER 250 may include nausea, diarrhea, abdominal pain, and headache. Rarely, it can cause more serious side effects such as liver problems or allergic reactions. If you experience any unusual symptoms while taking this medication, contact your doctor immediately.\n\nThe price of MYCOAZITHER 250 may vary depending on the brand and the quantity of tablets in each pack. It is available in pharmacies with a prescription from a healthcare professional.\n\nIn conclusion, MYCOAZITHER 250 containing Azithromycin 250mg is an effective antibiotic for treating various bacterial infections. Follow your doctor's instructions carefully for the best results and to minimize the risk of side effects.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \nhttps://www.sterisonline.com/product/mycoazither-250-134358\n\n\n\n\n\n\n", "price": 78.0, "discountamount": 23.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "risk", "food", "type", "body", "pack", "price", "Email", "brand", "nausea", "doctor", "dosage", "growth", "tablets", "diarrhea", "severity", "WhatsApp", "medicine", "diseases", "quantity", "headache", "chlamydia", "pneumonia", "treatment", "sinusitis", "wide range", "conclusion", "pharmacies", "bronchitis", "medication", "MYCOAZITHER", "information", "full course", "prescription", "sterispharma", "instructions", "sterisonline", "best results", "Azithromycin", "liver problems", "abdominal pain", "ear infections", "skin infections", "unusual symptoms", "allergic reactions", "effective antibiotic", "serious side effects", "healthcare professional", "various bacterial infections", "respiratory tract infections" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1445, "imageuri": "https://productimages.withfloats.com/actual/6661896353245b8b6b4a8b13.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661896353245b8b6b4a8b13.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T10:03:13.225Z", "updatedon": "2024-06-29T09:05:10.799Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mycoazither-250/1445", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOAZITHER 250", "category": "GENERAL RANGE", "tags": [ "MYCOAZITHER 250", "Azithromycin (250mg)", "Azithromycin 250 mg uses", "Azithromycin side effects", "Azithromycin गोली use", "Azithromycin dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665ef7cfea22b014e8aefff9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGLAZE MR 30 ", "description": "GLICLAGLAZE MR 30 \ngliclazide sr (30 mg)\nIntroduction\nGLICLAGLAZE MR 30 is specifically formulated for individuals managing Type 2 diabetes. This medication utilizes a sustained release (SR) form of Gliclazide at a 30 mg dosage, focusing on providing a steady, controlled release of the drug to maintain optimal blood sugar levels throughout the day.\n\nHow It Works\n\nGliclazide SR (30 mg): Gliclazide is a sulfonylurea class drug that increases insulin secretion from the pancreas. Unlike standard formulations, the SR version releases the medication gradually, which helps to stabilize blood sugar levels and reduces the risk of severe fluctuations that can lead to hypoglycemia. This mechanism not only enhances the body’s natural insulin use but also supports overall vascular health, decreasing the risk of complications associated with diabetes, such as cardiovascular disease.\nBenefits\nGLICLAGLAZE MR 30 is an excellent choice for patients who require a mild enhancement in their insulin secretion with a lower risk of hypoglycemia. The SR formulation provides a more predictable pharmacokinetic profile, which is crucial for maintaining a stable glycemic control. This can significantly improve the quality of life for patients by reducing common side effects associated with blood sugar spikes and drops.\n\nDosage and Administration\n\nDosage: The dose of GLICLAGLAZE MR 30 should be adjusted based on the patient’s blood glucose response and previous treatment history. Regular monitoring of blood glucose and glycated hemoglobin (HbA1c) levels is recommended to ensure that the dosage is effective.\nAdministration: This medication should be taken with breakfast or the first main meal of the day. The tablet should be swallowed whole to maintain the integrity of the sustained release mechanism.\nSide Effects\nPossible side effects of GLICLAGLAZE MR 30 include gastrointestinal issues such as nausea and upset stomach. Due to its sulfonylurea component, there is a risk of hypoglycemia, although it is generally lower compared to other sulfonylureas due to the sustained release formulation.\n\nConclusion\nGLICLAGLAZE MR 30 is a practical and effective solution for managing Type 2 diabetes, especially suited for patients seeking a gentle modification in their diabetes treatment plan with sustained drug release. It simplifies diabetes management, potentially enhancing adherence and minimizing the risk of dosage-related complications. As with any medication, consultation with a healthcare provider is essential to tailor the treatment to individual needs and conditions.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/gliclaglaze-mr-30-133422", "price": 83.0, "discountamount": 24.9, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "dose", "life", "body", "drops", "EMAIL", "Order", "upset", "tablet", "nausea", "stomach", "quality", "SR) form", "patients", "Benefits", "pancreas", "adherence", "integrity", "breakfast", "practical", "lower risk", "SR version", "medication", "conditions", "Conclusion", "individuals", "information", "sterisonline", "Introduction", "30 mg dosage", "consultation", "sterispharma", "hypoglycemia", "CALL/WHATSAPP", "Gliclazide SR", "HbA1c) levels", "SR formulation", "GLICLAGLAZE MR", "first main meal", "Type 2 diabetes", "mild enhancement", "individual needs", "excellent choice", "insulin secretion", "effective solution", "Regular monitoring", "blood sugar spikes", "healthcare provider", "diabetes management", "gentle modification", "other sulfonylureas", "common side effects", "glycated hemoglobin", "severe fluctuations", "natural insulin use", "Possible side effects", "standard formulations", "Administration Dosage", "sulfonylurea component", "sustained drug release", "blood glucose response", "cardiovascular disease", "diabetes treatment plan", "stable glycemic control", "gastrointestinal issues", "overall vascular health", "sulfonylurea class drug", "steady, controlled release", "optimal blood sugar levels", "previous treatment history", "sustained release mechanism", "dosage-related complications", "sustained release formulation", "predictable pharmacokinetic profile" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1291, "imageuri": "https://productimages.withfloats.com/actual/665ef7d253245b8b6b459895.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ef7d253245b8b6b459895.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:17:35.736Z", "updatedon": "2024-06-04T11:17:35.736Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/gliclaglaze-mr-30-/1291", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICLAGLAZE MR 30 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665ef6a3161afa2274ff2581", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGLAZE MET ", "description": "GLICLAGLAZE MET \ngliclazide SR (60mg),Metformin SR (500 mg)\nIntroduction\nGLICLAGLAZE MET is an advanced formulation designed for the effective management of Type 2 diabetes. This oral medication combines sustained release (SR) forms of Gliclazide (60 mg) and Metformin (500 mg), offering controlled and consistent blood glucose control throughout the day.\n\nMechanism of Action\n\nGliclazide SR (60 mg): As a sulfonylurea drug, Gliclazide SR works by stimulating insulin secretion from the beta cells of the pancreas. The sustained release form provides a gradual increase in insulin levels, reducing the risk of sudden drops in blood sugar that can lead to hypoglycemia.\nMetformin SR (500 mg): Metformin SR decreases hepatic glucose production and increases insulin sensitivity in peripheral tissues, notably muscles. Its sustained release formulation ensures a steady effect on blood sugar levels, improving metabolic response without the peaks and troughs associated with immediate-release forms.\nBenefits\nGLICLAGLAZE MET is specifically tailored to provide a more stable and prolonged effect in controlling blood sugar, which can enhance patient compliance and comfort. The combination of Gliclazide SR and Metformin SR in one tablet simplifies the treatment regimen, potentially improving adherence and reducing the risk of missed doses.\n\nDosage and Administration\n\nDosage: The dosage of GLICLAGLAZE MET should be individualized based on the patient's current control and therapeutic response. It is crucial to monitor blood glucose regularly to adjust the dosage appropriately.\nAdministration: This medication should be taken with meals to minimize gastrointestinal side effects and improve the absorption of the drug.\nSide Effects\nWhile GLICLAGLAZE MET is generally well tolerated, some patients may experience side effects such as gastrointestinal discomfort, including nausea and diarrhea. The risk of hypoglycemia is present but is generally lower with the sustained release formulation.\n\nConclusion\nGLICLAGLAZE MET offers a balanced and effective approach to managing Type 2 diabetes by combining two proven diabetes medications in a sustained release form. This regimen not only aids in maintaining steady blood glucose levels but also supports overall diabetes management by enhancing patient adherence to treatment. Patients are encouraged to maintain a dialogue with their healthcare provider to optimize treatment outcomes and address any concerns during their treatment journey.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/gliclaglaze-met-133421\n\n\n\n\n\n", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "risk", "Order", "EMAIL", "peaks", "doses", "meals", "stable", "Action", "nausea", "muscles", "troughs", "Benefits", "pancreas", "diarrhea", "balanced", "dialogue", "concerns", "patients", "SR) forms", "Mechanism", "beta cells", "Conclusion", "one tablet", "controlled", "absorption", "combination", "information", "Metformin SR", "sudden drops", "hypoglycemia", "Introduction", "sterispharma", "sterisonline", "steady effect", "CALL/WHATSAPP", "gliclazide SR", "insulin levels", "oral medication", "current control", "Type 2 diabetes", "GLICLAGLAZE MET", "gradual increase", "prolonged effect", "insulin secretion", "patient adherence", "treatment journey", "treatment regimen", "sulfonylurea drug", "effective approach", "blood sugar levels", "metabolic response", "peripheral tissues", "patient compliance", "treatment outcomes", "healthcare provider", "insulin sensitivity", "advanced formulation", "effective management", "therapeutic response", "Administration Dosage", "sustained release form", "immediate-release forms", "hepatic glucose production", "overall diabetes management", "steady blood glucose levels", "gastrointestinal discomfort", "gastrointestinal side effects", "two proven diabetes medications", "consistent blood glucose control" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1289, "imageuri": "https://productimages.withfloats.com/actual/665ef6a67b1fc3f9dd48259d.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ef6a67b1fc3f9dd48259d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:12:35.652Z", "updatedon": "2024-06-04T11:12:35.652Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//gliclaglaze-met-/1289", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICLAGLAZE MET ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665ef5bda743fd235821deeb", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGLAZE M 80 ", "description": "GLICLAGLAZE M 80 \ngliclazide (80mg),Metformin (500 mg)\nIntroduction\nGLICLAGLAZE M 80 is a specialized medication formulated for individuals diagnosed with Type 2 diabetes, aiming to enhance blood sugar regulation. This oral medication combines Gliclazide (80 mg) with Metformin (500 mg), two effective antidiabetic agents that provide a synergistic effect to control high blood sugar.\n\nMechanism of Action\n\nGliclazide (80 mg): Belonging to the sulfonylurea class, Gliclazide works by increasing insulin secretion from the pancreatic beta cells. It promotes a decrease in blood glucose levels and enhances the action of insulin in the body. Additionally, Gliclazide improves blood flow and has protective effects against the vascular complications of diabetes.\nMetformin (500 mg): Metformin reduces hepatic glucose production and improves insulin sensitivity by enhancing peripheral glucose uptake, particularly in muscle cells. This action helps lower blood glucose levels without the risk of inducing hypoglycemia and is associated with a potential reduction in body weight.\nBenefits\nGLICLAGLAZE M 80 offers a robust approach to managing Type 2 diabetes by targeting different aspects of the disease. The combination of Gliclazide and Metformin in this medication helps to control blood sugar more effectively than either component alone, potentially lowering the patient's risk of diabetes-related complications.\n\nDosage and Administration\n\nDosage: The starting dose should be adjusted based on the patient’s previous medication regimen, effectiveness, and tolerability. Dose adjustments should be made based on glycemic control, as assessed by regular monitoring of blood glucose levels.\nAdministration: It is recommended to take GLICLAGLAZE M 80 with meals to maximize drug absorption and minimize potential gastrointestinal side effects.\nSide Effects\nPotential side effects of GLICLAGLAZE M 80 include gastrointestinal symptoms like nausea and diarrhea, which usually improve over time. The risk of hypoglycemia exists but is moderated by the inclusion of Metformin.\n\nConclusion\nGLICLAGLAZE M 80 represents an effective treatment solution for managing Type 2 diabetes, combining two powerful antidiabetic agents to improve glycemic control and reduce the risk of diabetes complications. Patients should maintain regular consultations with their healthcare provider to tailor their treatment plan according to their specific needs, ensuring the best possible outcomes in diabetes management.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/gliclaglaze-m-80-133420\n\n\n\n\n\n", "price": 137.0, "discountamount": 41.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "risk", "time", "Order", "meals", "EMAIL", "nausea", "500 mg", "Action", "patient", "disease", "diarrhea", "Benefits", "decrease", "Mechanism", "Metformin", "component", "inclusion", "Conclusion", "blood flow", "gliclazide", "individuals", "information", "body weight", "combination", "Introduction", "muscle cells", "tolerability", "sterispharma", "hypoglycemia", "sterisonline", "starting dose", "effectiveness", "CALL/WHATSAPP", "GLICLAGLAZE M", "treatment plan", "specific needs", "Type 2 diabetes", "oral medication", "robust approach", "drug absorption", "high blood sugar", "Dose adjustments", "glycemic control", "different aspects", "insulin secretion", "regular monitoring", "sulfonylurea class", "synergistic effect", "protective effects", "healthcare provider", "insulin sensitivity", "potential reduction", "diabetes management", "blood glucose levels", "regular consultations", "pancreatic beta cells", "Administration Dosage", "best possible outcomes", "blood sugar regulation", "Potential side effects", "specialized medication", "diabetes complications", "vascular complications", "gastrointestinal symptoms", "peripheral glucose uptake", "hepatic glucose production", "previous medication regimen", "effective treatment solution", "diabetes-related complications", "two powerful antidiabetic agents", "two effective antidiabetic agents", "potential gastrointestinal side effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1287, "imageuri": "https://productimages.withfloats.com/actual/665ef5c0ca75628a5853ff45.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ef5c0ca75628a5853ff45.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:08:45.584Z", "updatedon": "2024-06-04T11:08:45.584Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//gliclaglaze-m-80-/1287", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICLAGLAZE M 80 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }